Trial intelligence / Profile preview

Hip Denervation and Intra-articular Hydration in Axial Spondyloarthritis

NCT05219084Phase 3Completed

Sponsor
Sohag University
Start
Dec 2021
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine, Normal Saline-Benha University in axial spondyloarthritis (axSpA), sponsored by Sohag University. Started Dec 2021; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrineNormal Saline-Benha University
03

Conditions

axial spondyloarthritis (axSpA)

Beyond the preview

Go deeper on NCT05219084.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05219084.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call